Filing Flows › Neurocrine Biosciences (NBIX) › Q2 2026
Neurocrine Biosciences (NBIX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Neurocrine Biosciences (NBIX) reported revenue of $959M for the second quarter 2026 (Q2 2026), +39% from a year earlier and +18% from the quarter before. Operating margin was 15.8%, net earnings $144M (15.1% of revenue).
Neurocrine Biosciences, Q2 2026: revenue $959M (+40% year over year), operating margin 15.8%, net earnings $144M, operating cash flow $136M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $959M | +18% | +39% |
| Operating profit | $152M | -22% | +4% |
| Net earnings | $144M | -27% | +34% |
| Operating cash flow | $136M | -6% | +34% |
| Free cash flow | $129M | -6% | +44% |
What changed
Revenue was $959.0M in Q2 2026, up 39% year over year and up 18% from the previous quarter. Net product sales was the largest line at 100% of revenue. Net product sales added $272.3M year over year (up 40%), 100% of the total change. Collaboration revenues declined 15%.
Operating profit was $151.5M, a 15.8% margin (down 5.4 points year over year). Of the extra revenue versus Q2 2025, 2% reached operating profit, below the 21% margin then. Total costs grew 49% against revenue growth of 39%. The fastest-growing cost line was Cost of revenue (+105%). Net earnings were $144.4M, up 34% year over year. The effective tax rate was 11.0%.
Operating cash flow was $136.4M (up 34% year over year), 94% of net earnings. Non-cash charges added back $24.8M of depreciation and amortization and $65.0M of share-based compensation. Working capital and other items used $97.8M. Capital expenditures of $7.8M left free cash flow of $128.6M.
Questions
What was Neurocrine Biosciences' revenue in the second quarter 2026?
Neurocrine Biosciences (NBIX) reported revenue of $959M for the second quarter 2026 (Q2 2026), +39% from a year earlier and +18% from the quarter before.
Was Neurocrine Biosciences profitable in the second quarter 2026?
Operating profit was $152M (15.8% of revenue) and net earnings $144M.